Bone turnover markers in patients with type 1 Gaucher disease

  • Gaetano Giuffrida | gagimapi@infinito.it Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.
  • Maria Rocca Cingari Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.
  • Nunziatina Parrinello Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.
  • Alessandra Romano Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.
  • Anna Triolo Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.
  • Magda Franceschino Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.
  • Francesco Di Raimondo Department of Clinical and Molecular Biomedicine, Division of Haematology, University of Catania, Ospedale Ferrarotto, Catania, Italy.

Abstract

Bone complications occur frequently in Gaucher disease (GD) and reduce the quality of life of these patients. Skeletal involvement is an important indication for treatment to ameliorate symptoms and reduce the risk of irreversible and debilitating disease. Bone biomarkers have been used to assess disease status and the response to therapy in a number of bone disorders. Here, we examine the literature for evidence of abnormalities in bone turnover markers in patients with type 1 GD to assess whether they might be useful for the assessment of bone involvement in GD. We have found that bone biomarkers in GD show highly variable results which do not currently support their routine use for clinical assessment of bone status, as an indication for therapy initiation, or for monitoring the response to therapy. A greater understanding of bone markers and their relation to the bone manifestations of GD is required.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2012-11-29
Info
Issue
Section
Reviews
Keywords:
Gaucher disease, bone, biomarkers, osteopenia
Statistics
  • Abstract views: 2575

  • PDF: 507
  • HTML: 140
How to Cite
Giuffrida, G., Cingari, M. R., Parrinello, N., Romano, A., Triolo, A., Franceschino, M., & Di Raimondo, F. (2012). Bone turnover markers in patients with type 1 Gaucher disease. Hematology Reports, 4(4), e21. https://doi.org/10.4081/hr.2012.e21